Manager's transactions
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| a. | Name | John Poulos |
| 2 | Reason for notification | |
| a. | Position/Status | Non-executive Director |
| b. | Initial notification/ Amendment | Initial Notification |
| a. | Name | Faron Pharmaceuticals Oy |
| b. | LEI | 7437009H31TO1DC0EB42 |
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary shares ISIN: FI4000153309 |
| b. | Nature of the transaction | 1) Disposal of ordinary shares (October 3, 2023) 2) Disposal of ordinary shares (October 12, 2023) |
| c. | Price(s) and volume(s) | |
| Price(s) | Volume(s) | |
| 1) €3.7209 2) €3.8259 | 1) 5,000 2) 5,000 | |
| d. | Aggregated information - Aggregated Volume - Price | 1) 5,000 2) 5,000 1) €3.7209 2) €3.8259 |
| f. | Place of the transaction | Nasdaq First North Growth Market |
About Faron Pharmaceuticals Ltd.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.